NeutriSci Pb Ratio vs Ev To Sales Analysis

NU Stock

CAD 12.53 1.00 7.39%

NeutriSci International financial indicator trend analysis is infinitely more than just investigating NeutriSci International recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeutriSci International is a good investment. Please check the relationship between NeutriSci International Pb Ratio and its Ev To Sales accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeutriSci International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Pb Ratio vs Ev To Sales

Pb Ratio vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeutriSci International Pb Ratio account and Ev To Sales. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between NeutriSci International's Pb Ratio and Ev To Sales is -0.14. Overlapping area represents the amount of variation of Pb Ratio that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of NeutriSci International, assuming nothing else is changed. The correlation between historical values of NeutriSci International's Pb Ratio and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pb Ratio of NeutriSci International are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Pb Ratio i.e., NeutriSci International's Pb Ratio and Ev To Sales go up and down completely randomly.

Correlation Coefficient

-0.14

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Pb Ratio

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from NeutriSci International's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeutriSci International current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeutriSci International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to drop to about 416.6 K in 2024. Issuance Of Capital Stock is likely to drop to about 168.2 K in 2024

NeutriSci International fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Other Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Non Current Assets Total	Inventory	Other Current Assets	Non Currrent Assets Other	Short Long Term Debt Total	Short Term Debt	Other Current Liab	Net Tangible Assets	Good Will	Short Long Term Debt
Total Assets		0.28	0.55	-0.19	0.69	-0.04	0.49	0.84	-0.55	0.28	0.96	-0.59	0.42	-0.22	0.27	-0.21	0.27	0.59	-0.16	-0.1	-0.05	0.16	0.19	0.08	0.21	0.61
Total Current Liabilities	0.28		-0.65	0.88	0.54	-0.27	-0.07	0.33	-0.53	1.0	0.2	-0.64	0.65	-0.19	-0.02	-0.16	0.02	0.73	0.02	-0.01	0.93	0.98	0.2	-0.16	0.1	0.73
Total Stockholder Equity	0.55	-0.65		-0.92	0.08	0.21	0.45	0.37	0.03	-0.65	0.59	0.09	-0.25	0.0	0.23	-0.03	0.19	-0.17	-0.16	-0.08	-0.85	-0.73	-0.03	0.21	0.07	-0.16
Net Debt	-0.19	0.88	-0.92		0.27	-0.26	-0.29	-0.06	-0.34	0.88	-0.24	-0.41	0.47	-0.08	-0.2	-0.05	-0.15	0.51	0.1	0.0	0.98	0.93	0.16	-0.16	0.09	0.49
Retained Earnings	0.69	0.54	0.08	0.27		-0.1	0.26	0.65	-0.86	0.53	0.68	-0.94	0.65	-0.05	-0.11	-0.37	-0.09	0.91	-0.14	-0.4	0.37	0.49	0.12	0.15	0.24	0.93
Cash	-0.04	-0.27	0.21	-0.26	-0.1		0.81	0.08	-0.17	-0.27	0.2	-0.03	-0.64	0.82	-0.41	-0.14	-0.41	-0.36	0.3	-0.55	-0.13	-0.21	-0.03	0.83	0.08	-0.22
Cash And Short Term Investments	0.49	-0.07	0.45	-0.29	0.26	0.81		0.52	-0.41	-0.07	0.65	-0.32	-0.3	0.57	-0.36	-0.22	-0.36	0.0	0.25	-0.64	-0.12	-0.08	0.07	0.72	0.15	0.13
Net Receivables	0.84	0.33	0.37	-0.06	0.65	0.08	0.52		-0.65	0.33	0.82	-0.58	0.25	0.11	0.02	-0.32	0.0	0.48	-0.37	-0.27	0.09	0.26	0.2	0.29	0.31	0.51
Common Stock Shares Outstanding	-0.55	-0.53	0.03	-0.34	-0.86	-0.17	-0.41	-0.65		-0.52	-0.61	0.9	-0.39	-0.27	0.26	0.35	0.25	-0.78	0.08	0.47	-0.47	-0.55	-0.26	-0.47	-0.58	-0.83
Total Liab	0.28	1.0	-0.65	0.88	0.53	-0.27	-0.07	0.33	-0.52		0.2	-0.64	0.66	-0.2	-0.02	-0.16	0.03	0.73	0.02	0.0	0.93	0.98	0.2	-0.17	0.1	0.73
Total Current Assets	0.96	0.2	0.59	-0.24	0.68	0.2	0.65	0.82	-0.61	0.2		-0.61	0.25	-0.02	0.15	-0.21	0.15	0.52	-0.09	-0.25	-0.07	0.11	0.22	0.31	0.28	0.56
Common Stock	-0.59	-0.64	0.09	-0.41	-0.94	-0.03	-0.32	-0.58	0.9	-0.64	-0.61		-0.54	-0.07	0.2	0.35	0.18	-0.88	0.1	0.45	-0.53	-0.62	-0.2	-0.25	-0.26	-0.92
Accounts Payable	0.42	0.65	-0.25	0.47	0.65	-0.64	-0.3	0.25	-0.39	0.66	0.25	-0.54		-0.54	0.27	-0.2	0.29	0.83	-0.01	0.09	0.47	0.58	0.02	-0.57	0.02	0.8
Other Stockholder Equity	-0.22	-0.19	0.0	-0.08	-0.05	0.82	0.57	0.11	-0.27	-0.2	-0.02	-0.07	-0.54		-0.5	-0.11	-0.53	-0.29	0.07	-0.72	0.0	-0.1	0.16	0.75	0.19	-0.17
Property Plant And Equipment Net	0.27	-0.02	0.23	-0.2	-0.11	-0.41	-0.36	0.02	0.26	-0.02	0.15	0.2	0.27	-0.5		0.2	1.0	0.05	-0.36	0.64	-0.22	-0.08	0.28	-0.47	-0.01	0.0
Current Deferred Revenue	-0.21	-0.16	-0.03	-0.05	-0.37	-0.14	-0.22	-0.32	0.35	-0.16	-0.21	0.35	-0.2	-0.11	0.2		0.2	-0.19	0.24	0.17	-0.12	-0.13	0.43	-0.31	0.04	-0.27
Non Current Assets Total	0.27	0.02	0.19	-0.15	-0.09	-0.41	-0.36	0.0	0.25	0.03	0.15	0.18	0.29	-0.53	1.0	0.2		0.08	-0.31	0.66	-0.17	-0.03	0.27	-0.48	-0.02	0.03
Inventory	0.59	0.73	-0.17	0.51	0.91	-0.36	0.0	0.48	-0.78	0.73	0.52	-0.88	0.83	-0.29	0.05	-0.19	0.08		-0.06	-0.17	0.57	0.69	0.23	-0.13	0.28	0.98
Other Current Assets	-0.16	0.02	-0.16	0.1	-0.14	0.3	0.25	-0.37	0.08	0.02	-0.09	0.1	-0.01	0.07	-0.36	0.24	-0.31	-0.06		-0.16	0.12	0.03	-0.32	-0.02	-0.08	0.0
Non Currrent Assets Other	-0.1	-0.01	-0.08	0.0	-0.4	-0.55	-0.64	-0.27	0.47	0.0	-0.25	0.45	0.09	-0.72	0.64	0.17	0.66	-0.17	-0.16		-0.09	-0.04	-0.18	-0.53	-0.06	-0.26
Short Long Term Debt Total	-0.05	0.93	-0.85	0.98	0.37	-0.13	-0.12	0.09	-0.47	0.93	-0.07	-0.53	0.47	0.0	-0.22	-0.12	-0.17	0.57	0.12	-0.09		0.97	0.19	-0.03	0.14	0.58
Short Term Debt	0.16	0.98	-0.73	0.93	0.49	-0.21	-0.08	0.26	-0.55	0.98	0.11	-0.62	0.58	-0.1	-0.08	-0.13	-0.03	0.69	0.03	-0.04	0.97		0.26	-0.08	0.19	0.69
Other Current Liab	0.19	0.2	-0.03	0.16	0.12	-0.03	0.07	0.2	-0.26	0.2	0.22	-0.2	0.02	0.16	0.28	0.43	0.27	0.23	-0.32	-0.18	0.19	0.26		0.11	0.44	0.18
Net Tangible Assets	0.08	-0.16	0.21	-0.16	0.15	0.83	0.72	0.29	-0.47	-0.17	0.31	-0.25	-0.57	0.75	-0.47	-0.31	-0.48	-0.13	-0.02	-0.53	-0.03	-0.08	0.11		0.38	-0.04
Good Will	0.21	0.1	0.07	0.09	0.24	0.08	0.15	0.31	-0.58	0.1	0.28	-0.26	0.02	0.19	-0.01	0.04	-0.02	0.28	-0.08	-0.06	0.14	0.19	0.44	0.38		0.27
Short Long Term Debt	0.61	0.73	-0.16	0.49	0.93	-0.22	0.13	0.51	-0.83	0.73	0.56	-0.92	0.8	-0.17	0.0	-0.27	0.03	0.98	0.0	-0.26	0.58	0.69	0.18	-0.04	0.27

Click cells to compare fundamentals

NeutriSci International Account Relationship Matchups

NeutriSci International fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	504.8K	528.3K	819.5K	331.4K	381.1K	362.1K
Total Current Liabilities	661.1K	618.5K	807.1K	888.4K	799.6K	1.4M
Total Stockholder Equity	(156.2K)	(90.2K)	(47.6K)	(617.0K)	(709.5K)	(745.0K)
Net Debt	45.7K	(7.4K)	29.3K	3.4K	3.0K	2.9K
Retained Earnings	(32.2M)	(34.1M)	(35.7M)	(36.5M)	(32.8M)	(31.2M)
Cash	100.0	7.4K	30.7K	175.3K	157.7K	224.4K
Cash And Short Term Investments	100.0	7.4K	30.7K	175.3K	157.7K	235.0K
Net Receivables	21.1K	12.4K	11.9K	8.8K	10.1K	9.6K
Common Stock Shares Outstanding	116.0M	143.4M	158.6M	166.2M	191.1M	200.6M
Liabilities And Stockholders Equity	504.8K	528.3K	819.5K	331.4K	381.1K	688.3K
Total Liab	661.1K	618.5K	867.1K	948.4K	853.6K	1.4M
Total Current Assets	485.5K	313.6K	649.9K	199.1K	229.0K	217.5K
Common Stock	28.1M	29.6M	30.9M	31.0M	35.7M	24.7M
Accounts Payable	478.9K	524.5K	439.8K	733.5K	843.6K	501.6K
Other Stockholder Equity	3.6M	4.2M	4.5M	4.6M	5.3M	5.0M
Property Plant And Equipment Net	19.3K	214.7K	169.1K	132.3K	119.1K	62.5K
Non Current Assets Total	19.3K	214.7K	169.1K	132.3K	119.1K	62.2K
Inventory	344.4K	273.0K	494.8K	15K	13.5K	12.8K
Other Current Assets	61.1K	119.8K	20.8K	112.5K	129.4K	79.3K
Other Current Liab	100.1K	582.3K	569.9K	36.2K	41.7K	39.6K
Net Tangible Assets	275.8K	(156.2K)	(90.2K)	(617.0K)	(555.3K)	(527.5K)
Net Invested Capital	(110.5K)	(90.2K)	12.4K	(438.3K)	(394.5K)	(374.8K)
Net Working Capital	(175.6K)	(304.9K)	(157.2K)	(689.3K)	(620.4K)	(589.4K)
Capital Stock	28.1M	29.6M	30.9M	31.0M	35.7M	32.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for NeutriSci Stock Analysis

When running NeutriSci International's price analysis, check to measure NeutriSci International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeutriSci International is operating at the current time. Most of NeutriSci International's value examination focuses on studying past and present price action to predict the probability of NeutriSci International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeutriSci International's price. Additionally, you may evaluate how the addition of NeutriSci International to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC